Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Danese

Showing results (81-90 of 82) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 82 results.
Archives of Ophthalmology (Chicago, Ill. : 1960)|June 15, 2011
Estimated cases of legal blindness and visual impairment avoided using ranibizumab for choroidal neovascularization: non-Hispanic white population in the United States with age-related macular degenerationNeil M Bressler, Quan V Doan, Rohit Varma, et al.
BMC Nephrology|November 6, 2016
Facility-level CKD-MBD composite score and risk of adverse clinical outcomes among patients on hemodialysisGeoffrey A Block, Akeem A Yusuf, Mark D Danese, et al.
Pageof 9

Showing results (81-90 of 82) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 82 results.
Archives of Ophthalmology (Chicago, Ill. : 1960)|June 15, 2011
Estimated cases of legal blindness and visual impairment avoided using ranibizumab for choroidal neovascularization: non-Hispanic white population in the United States with age-related macular degenerationNeil M Bressler, Quan V Doan, Rohit Varma, et al.
BMC Nephrology|November 6, 2016
Facility-level CKD-MBD composite score and risk of adverse clinical outcomes among patients on hemodialysisGeoffrey A Block, Akeem A Yusuf, Mark D Danese, et al.
Pageof 9